Abstract
The assignment with chromosome banding techniques of the breakpoints of the recurrent translocation t(3;5) which leads to NPM1/MLF1 gene fusion in myeloid malignancies has not been unequivocal. In order to assess whether this is due to uncertainty in interpretation of the observed banding pattern or whether it reflects true genomic heterogeneity, we decided to analyze the breakpoint positions using fluorescence in situ (FISH) techniques in eight patients with myeloid malignancies and rearrangements of chromosomes 3 and 5. In three patients, colocalization of the NPM1 and MLF1 spanning BACs was demonstrated and NPM1/MLF1 fusion shown by PCR in one while in the remaining cases breakpoints were located outside the NPM1 and MLF1 loci. Interestingly, loss of a copy of the NPM1 gene was found in three of these latter patients. This findings suggest that haploinsufficiency of NPM1 may play a role in subtypes of myelodysplasias and leukemias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rowley JD, Potter D . Chromosomal banding patterns in acute nonlymphocytic leukemia. Blood 1976; 47: 705–721.
Oshimura M, Hayata I, Kakati S, Sandberg AA . Chromosomes and causation of human cancer and leukemia. XVII. Banding studies in acute myeloblastic leukemia (AML). Cancer 1976; 38: 748–761.
Mitelman F, Johansson B, Mertens F (eds). Mitelman Database of Chromosome Aberrations in Cancer (2005). http://cgap.nci.nih.gov/Chromosomes/Mitelman.
Raimondi SC, Dubé I, Valentine MB, Mirro Jr J, Watt HJ, Larson RA et al. Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia. Leukemia 1989; 3: 42–47.
Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ et al. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NMP-MLF1. Oncogene 1996; 12: 265–275.
Romana SP, Le Coniat M, Berger R . t(12;21): a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromosomes Cancer 1994; 9: 186–191.
Pallisgaard N, Hokland P, Riishøj DC, Pedersen B, Jørgensen P . Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574–588.
Pedersen B . Anatomy of the 5q-deletion: different sex ratios and deleted 5q bands in MDS and AML. Leukemia 1996; 10: 1883–1890.
Nagarajan L, Lange B, Cannizzaro L, Finan J, Nowell PC, Huebner K . Molecular anatomy of a 5q interstitial deletion. Blood 1990; 75: 82–87.
Nagarajan L, Zhao L, Lu X, Warrington J, Wasmuth JJ, Siciliano M et al. 5q-chromosome: evidence for complex interstitial breaks in a case of refractory anemia with excess of blasts. Cancer Genet Cytogenet 1994; 74: 8–12.
Matsumoto N, Yoneda-Kato N, Iguchi T, Kishimoto Y, Kyo Y, Sawada H et al. Elevated MLF1 expression correlates with malignant progression from myelodysplastic syndrome. Leukemia 2000; 14: 1757–1765.
Arber DA, Chang KL, Lyda MH, Bedell V, Spielberger R, Slovak ML . Detection of NPM/MLF1 fusion in t(3;5)-positive acute myloid leukemia and myelodysplasia. Hum Pathol 2003; 34: 809–813.
Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005; 437: 147–153.
Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, et al., for the Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto (GIMEMA) Acute leukemia Working Party. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899–902.
Cazzaniga G, Dell’Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 2005; 106: 1419–1422.
Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, et al., for the GIMEMA Acute Leukemia Working Party. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254–266.
Acknowledgements
We thank Drs M Nunault, S François, M Gardembas and F Geneviève (CHRU, Angers, France) and Drs E Duchayne, F Huguet, A Robert. (Hôpital Purpan, Toulouse, France).
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Berger, R., Busson, M., Baranger, L. et al. Loss of the NPM1 gene in myeloid disorders with chromosome 5 rearrangements. Leukemia 20, 319–321 (2006). https://doi.org/10.1038/sj.leu.2404063
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404063
Keywords
This article is cited by
-
Current views on the genetic landscape and management of variant acute promyelocytic leukemia
Biomarker Research (2021)
-
NPM1 Biology in Myeloid Neoplasia
Current Hematologic Malignancy Reports (2020)
-
Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases
Oncogene (2011)
-
The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer
Prostate Cancer and Prostatic Diseases (2010)
-
Nucleophosmin and cancer
Nature Reviews Cancer (2006)